Gut Region-Specific Diabetic Damage to the Capillary Endothelium Adjacent to the Myenteric Plexus

Microcirculation

Volumn 19, Issue 4, 2012, Pages 316-326

  Bódi, Nikolett ^a   Talapka, Petra ^a   Poles, Marietta Zita ^a   Hermesz, Edit ^b   Jancsó, Zsanett ^b   Katarova, Zója ^c   Izbéki, Ferenc ^d   Wittmann, Tibor ^d   Fekete, Éva ^a   Bagyánszki, Mária ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Enteric neuropathy; Gut segment specificity; Insulin replacement; Microvascular disease; STZ induced diabetes

Indexed keywords

ALBUMIN; CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BODY WEIGHT; CAPILLARY ENDOTHELIUM; CAVEOLA; COLON; CONTROLLED STUDY; DIABETES MELLITUS; DUODENUM; ENDOTHELIUM CELL; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; ILEUM; IMMUNOHISTOCHEMISTRY; INSULIN TREATMENT; MICROVASCULATURE; MYENTERIC PLEXUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; STREPTOZOCIN DIABETES; TIGHT JUNCTION;

ANIMALS; CAVEOLIN 1; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; MALE; MYENTERIC PLEXUS; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 84860229080     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/j.1549-8719.2012.00164.x     Document Type: Article

References (47)

1. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 47(12): 1953-1959, 1998.
2. Barnett AH. Pathogenesis of diabetic microangiopathy: an overview. Am J Med 90(6A): 67S-73S, 1991.
3. Burcelin R, Serino M, Chabo C, Blasco-Baque V, Amar J. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol 48(4): 257-273, 2011.
4. Burns AJ, Pachnis V. Development of the enteric nervous system: bringing together cells, signals and genes. Neurogastroenterol Motil 21(2): 100-102, 2009.
5. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15, 000 adults. Arch Intern Med 161(16): 1989-1996, 2001.
6. Chronopoulos A, Tang A, Beglova E, Trackman PC, Roy S. High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function. Diabetes 59(12): 3159-3166, 2010.
7. Chronopoulos A, Trudeau K, Roy S, Huang H, Vinores SA, Roy S. High glucose-induced altered basement membrane composition and structure increases trans-endothelial permeability: implications for diabetic retinopathy. Curr Eye Res 36(8): 747-753, 2011.
8. De Las Casas LE, Finley JL. Diabetic microangiopathy in the small bowel. Histopathology 35(3): 267-270, 1999.
9. Doodnath R, Wride M, Puri P. The spatio-temporal patterning of Hoxa9 and Hoxa13 in the developing zebrafish enteric nervous system. Pediatr Surg Int 28(2): 115-121, 2012.
10. Fioretto P, Mauer M. Histopathology of diabetic nephropathy. Semin Nephrol 27(2): 195-207, 2007.
11. Fortes ZB, Garcia Leme J, Scivoletto R. Vascular reactivity in diabetes mellitus: role of the endothelial cell. Br J Pharmacol 79(3): 771-781, 1983.
12. Gao N, White P, Kaestner KH. Establishment of intestinal identity and epithelial-mesenchymal signaling by Cdx2. Dev Cell 16(4): 588-599, 2009.
13. Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S, Wang ZV, Landskroner-Eiger S, Dineen S, Magalang UJ, Brekken RA, Scherer PE. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 29(16): 4467-4483, 2009.
14. Harhaj NS, Antonetti DA. Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 36(7): 1206-1237, 2004.
15. Hracsko Z, Hermesz E, Ferencz A, Orvos H, Novak Z, Pal A, Varga IS. Endothelial nitric oxide synthase is up-regulated in the umbilical cord in pregnancies complicated with intrauterine growth retardation. In Vivo 23(5): 727-732, 2009.
16. Hu G, Ye RD, Dinauer MC, Malik AB, Minshall RD. Neutrophil caveolin-1 expression contributes to mechanism of lung inflammation and injury. Am J Physiol Lung Cell Mol Physiol 294(2): L178-L186, 2008.
17. Izbéki F, Wittman T, Rosztóczy A, Linke N, Bódi N, Fekete E, Bagyánszki M. Immediate insulin treatment prevents gut motility alterations and loss of nitrergic neurons in the ileum and colon of rats with streptozotocin-induced diabetes. Diabetes Res Clin Pract 80(2): 192-198, 2008.
18. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sørensen SJ, Hansen LH, Jakobsen M. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 5(2): e9085, 2010.
19. Lee JH, Bahk JH, Park SH, Huh J. The diabetes-induced functional and distributional changes of the alpha 1-adrenoceptor of the abdominal aorta and distal mesenteric artery from streptozotocin-induced diabetic rats. Korean J Anesthesiol 60(4): 272-281, 2011.
20. Lee SE, Ma W, Rattigan EM, Aleshin A, Chen L, Johnson LL, D'Agati VD, Schmidt AM, Barile GR. Ultrastructural features of retinal capillary basement membrane thickening in diabetic swine. Ultrastruct Pathol 34(1): 35-41, 2010.
21. Li H, Brodsky S, Basco M, Romanov V, De Angelis DA, Goligorsky MS. Nitric oxide attenuates signal transduction: possible role in dissociating caveolin-1 scaffold. Circ Res 88(2): 229-236, 2001.
22. Ljubimov AV, Burgeson RE, Butkowski RJ, Couchman JR, Zardi L, Ninomiya Y, Sado Y, Huang ZS, Nesburn AB, Kenney MC. Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem 44(12): 1469-1479, 1996.
23. Matveev S, Uittenbogaard A, van Der Westhuyzen D, Smart EJ. Caveolin-1 negatively regulates SR-BI mediated selective uptake of high-density lipoprotein-derived cholesteryl ester. Eur J Biochem 268(21): 5609-5616, 2001.
24. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 86(1): 279-367, 2006.
25. Mompeo B, Popov D, Sima A, Constantinescu E, Simionescu M. Diabetes-induced structural changes of venous and arterial endothelium and smooth muscle cells. J Submicrosc Cytol Pathol 30(4): 475-484, 1998.
26. Nusrat A, Parkos CA, Verkade P, Foley CS, Liang TW, Innis-Whitehouse W, Eastburn KK, Madara JL. Tight junctions are membrane microdomains. J Cell Sci 113(Pt. 10): 1771-1781, 2000.
27. Ördög T, Hayashi Y, Gibbons SJ. Cellular pathogenesis of diabetic gastroenteropathy. Minerva Gastroenterol Dietol 55(3): 315-343, 2009.
28. Pascariu M, Bendayan M, Ghitescu L. Correlated endothelial caveolin overexpression and increased transcytosis in experimental diabetes. J Histochem Cytochem 52(1): 65-76, 2004.
29. Rosztóczy A, Róka R, Várkonyi TT, Lengyel C, Izbéki F, Lonovics J, Wittmann T. Regional differences in the manifestation of gastrointestinal motor disorders in type 1 diabetic patients with autonomic neuropathy. Z Gastroenterol 42(11): 1295-1300, 2004.
30. Roy S, Sato T, Paryani G, Kao R. Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes 52(5): 1229-1234, 2003.
31. Roy S, Trudeau K, Roy S, Behl Y, Dhar S, Chronopoulos A. New insights into hyperglycemia-induced molecular changes in microvascular cells. J Dent Res 89(2): 116-127, 2010.
32. Sbaa E, Frérart F, Feron O. The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: a paradox solved through the study of angiogenesis. Trends Cardiovasc Med 15(5): 157-162, 2005.
33. Schenkel AR, Mamdouh Z, Chen X, Liebman RM, Muller WA. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat Immunol 3(2): 143-150, 2002.
34. Schubert W, Frank PG, Woodman SE, Hyogo H, Cohen DE, Chow CW, Lisanti MP. Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice. J Biol Chem 277(42): 40091-40098, 2002.
35. Simionescu M, Gafencu A, Antohe F. Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey. Microsc Res Tech 57(5): 269-288, 2002.
36. Simionescu M, Popov D, Sima A. Endothelial transcytosis in health and disease. Cell Tissue Res 335(1): 27-40, 2009.
37. 2+ resorption. Science 285(5424): 103-106, 1999.
38. Song L, Ge S, Pachter JS. Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells. Blood 109(4): 1515-1523, 2007.
39. Tuma PL, Hubbard AL. Transcytosis: crossing cellular barriers. Physiol Rev 83(3): 871-932, 2003.
40. Várkonyi TT, Lengyel C, Madácsy L, Velösy B, Kempler P, Fazekas T, Pávics L, Csernay L, Lonovics J. Gallbladder hypomotility in diabetic polyneuropathy. Clin Auton Res 11(6): 377-381, 2001.
41. Verne GN, Sninsky CA. Diabetes and the gastrointestinal tract. Gastroenterol Clin North Am 27(4): 861-874, vi-vii, 1998.
42. Vinores SA, Derevjanik NL, Mahlow J, Berkowitz BA, Wilson CA. Electron microscopic evidence for the mechanism of blood-retinal barrier breakdown in diabetic rabbits: comparison with magnetic resonance imaging. Pathol Res Pract 194(7): 497-505, 1998.
43. Watkins CC, Sawa A, Jaffrey S, Blackshaw S, Barrow RK, Snyder SH, Ferris CD. Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest 106(3): 373-384, 2000.
44. Wells JM, Rossi O, Meijerink M, van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A 108(Suppl. 1): 4607-4614, 2011.
45. Wrzos HF, Cruz A, Polavarapu R, Shearer D, Ouyang A. Nitric oxide synthase (NOS) expression in the myenteric plexus of streptozotocin-diabetic rats. Dig Dis Sci 42(10): 2106-2110, 1997.
46. Zhang Q, Furukawa K, Chen HH, Fujinawa R, Kozutsumi Y, Suzuki A, Urano T, Furukawa K. Down-regulation of caveolin-1 in mouse Lewis lung cancer P29 is a causal factor for the malignant properties in a high-metastatic subline. Oncol Rep 16(2): 289-294, 2006.
47. Zhu WW, Chen HP, Ge YC, Xie HL, Zeng CH, Li LS, Liu ZH. Ultrastructural changes in the glomerular filtration barrier and occurrence of proteinuria in Chinese patients with type 2 diabetic nephropathy. Diabetes Res Clin Pract 86(3): 199-207, 2008.